Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -50.00p -2.00% 2,456.00p 2,456.00p 2,459.00p 2,507.00p 2,452.00p 2,507.00p 103,532 13:55:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 102.2 34.3 23.9 102.9 2,833.39

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
19/2/201810:17FEVER TREE with chart2,178
31/1/201815:22Fevertree Drinks PLC (Fever-Tree)1,471
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:01:132,458.70882,163.66O
13:51:092,456.0020491.20AT
13:51:092,456.002506,140.00AT
13:45:412,454.001453,558.30AT
13:45:012,455.001072,626.85AT
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

DateSubject
19/2/2018
08:20
Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 2,506p.
Fevertree Drinks has a 4 week average price of 2,275p and a 12 week average price of 1,866p.
The 1 year high share price is 2,685p while the 1 year low share price is currently 1,323p.
There are currently 115,366,102 shares in issue and the average daily traded volume is 347,042 shares. The market capitalisation of Fevertree Drinks is £2,831,084,143.08.
14/2/2018
12:27
villarich: Thanks! These are my calcs so far. I've pencilled in 50% EPS growth for 2018 (conservative) and will refine after results next month. Based on 39.6p EPS for 2017, then 2018 EPS is 59.4p. On a 50x multiple, I get a share price of £29.70. Any higher EPS would impact that as I'd raise the 2018 EPs target and multiplier too - depending on how good the results are.
30/1/2018
22:09
christh: wet wet wet nightmare, how is Coventry? You are filtered! £26 is coming soon, results are due soon and will get share price to £28. If there is an offer on the table will come out when the results are announced Who the suitor be or would a hostile bidder emerge? Buy fevertree shares, for a profitable journey! Higher and higher will go!
26/1/2018
20:44
villarich: I'm sorry but which part of the article is bad? Can you quote it please? Or are you only saying it's bad because a) it isn't saying what you want, and b) you don't understand it??He's gushing about the results and makes the obvious statement that future growth is priced in and any updates that fall short of this would result in a fall in the share price. Isn't that logical? He's not negative of Boohoo, he's using it as an example of what MIGHT happen with Fevertree if growth undergoes expectations. Also look at the BOO chart. Doesn't make good viewing over the last 12 months.Oh and you've never heard of Wetherspoons? FML!!!
24/1/2018
19:31
devalpha: Interesting reading through all today's posts.Why all the emotion around the short term daily share price? If we're serious about this investing game we should all be focussing on the business and not short term price movements. If they continue to grow rapidly, then the price will deliver over the longer term. That's what needs to be assessed....can the growth rate be maintained?As for takeover rumours....I just don't buy it at the price a major co. would need to lay out to acquire circa £3.25billion. Doesn't make sense for me.Assembling a strong team to make them serious players in the US however for me makes a lot of sense. Hopefully we've only seen the start of the assembling.
24/1/2018
14:24
villarich: I've done some really rough analysis based on the limited financial information given in today's update to see where the share price might go over the next year or so. They are really rough figures with roundings but hopefully it all makes sense. I'll revisit when the full results are released. Last years reported Post-Tax Profit was £27.5m from revenues of £102m (roughly 27% of revenue was turned into PTP). Using that percentage on today's reported revenue figure, I'm getting £45.6m in profit which gives us EPS of 39.6p. I've rounded this to 40p for ease. I get a current multiple of 104 based on 24p EPS. If we applied 104 to 40p EPS we get a share price of £41. It would be wrong though to apply 104 to this EPS because the current multiple has that growth factored in. If we apply a multiple of 60 (this time last year the multiple was around 60) to 40p EPS we get £24. Right where we are now. If EPS does come in at 40p then EPS growth is 66%. Let's assume growth continues at a similar, albeit slightly lower pace of 50% this year. That gives us an EPS of 60p in 2018. Applying a multiple of 60 to that gives us a share price of £35.64. Again it's probably wrong to apply the same multiple again so a multiple of 50 gives us an share price of £29.70 (18% up from now). As I said there's loads of assumptions in here but I'd be interested to see the EPS in the full results and will revisit my thoughts. Overall, I won't be selling any time soon. Then again I wont be topping up either. It's a hold for me.
16/1/2018
13:20
christh: you will not see this price again come next week. Next wednesday is the trading update and we will see brokers raising the target prices. We already know some brokers said £24. On the other hand it might be a surprise to find someone bidding for them. But who? Unilever now entered the scene along Diageo but many others are ready to pounce. Fevertree will make a perfect aquisition for a big consumer company/Drinks company as it would to its profits as well as increase sales. A bidder has to offer the highest price achieved of the share price +10% So £28 will be a good price. But remember you have to be in to win!
29/12/2017
09:09
villarich: The stock hit £25 earlier in the year because it released a trading update that surpassed market expectations. It didn't rise because of 'no particular data' as you claim. The reason it has dropped from there is because the market was expecting more of the same and FEVR didn't quite live up to expectation (despite it still being a cracking update). The thing with these high PE, fast growth shares is if you undershoot market expectations by a smidge then the share could drop - see BOO as another recent example.Also I don't buy into setting target prices based on what it's done in the past and what some bloke on a bulletin board says it could be. Don't get me wrong, I hope it does hit £35 and beyond and I'm sure it will in the years to come, but just as Christh does, spouting some random number that is higher than the current share price is a bit tiresome.
13/11/2017
17:22
monnow: Artisan have bought a big chunk, so dropping the share price and a bit of verbal diarrhoea from press tipsters seems to have worked a treat in relieving PI's of some of their shares. Why would they stop now? if I was them I would carry on buying with this new market paradigm of the more we buy the further the share price falls ??
22/6/2017
16:07
sogoesit: The article excerpt referred to in post 1013: "Fevertree (FEVR:AIM) £16.05 Current market status: LOVED Fevertree’s tonic water is increasingly the gin lover’s mixer of choice as it is considered a high quality product. The company has succeeded in getting its products stocked in a wide range of places, from supermarkets and restaurants to airlines and pubs. Fevertree has an asset-light, outsourced production model that means it is very cash generative and able to pay a progressive dividend. Its share price has risen 12-fold in value since joining the stock market in 2014. It has developed a reputation for providing conservative earnings guidance to analysts and subsequently over-delivering when financial numbers are reported. That has led to a continuous stream of earnings upgrades which have fuelled significant share price gains. FEVR - Comparison Line Chart (Rebased to first) WHAT ARE THE NEGATIVE POINTS FOR THE INVESTMENT CASE? 1. Could struggle to crack dark spirit market It is betting on a repeat of its tonic water success in the dark spirit mixers category. We think that’s a tall order. The market could punish the share price if the company cannot crack this market to same degree as it has done with light spirit mixers. Gin (a light spirit) and tonic is a refreshing drink where consumers clearly want high quality from both the spirit and the mixer, hence why Fevertree has done so well. However, dark spirits tend to be drunk neat, such as brandy, bourbon and whisky, so no need for fancy mixers. A mixer could cover up the true taste of whisky, for example, which defeats the object of enjoying that type of spirit. Water or ice would be acceptable mixers for whisky, but you don’t need a Fevertree-branded product. As for something like whisky and cola, surely that is the preferred drink of someone who is going after quantity over quality? Fevertree is now selling Madagascan Cola, which it claims to enhance ‘the complex flavours’ of the finest rums, whiskies and bourbons. Convincing shophisticated whisky drinkers to start adding cola to their favourite tipple will be a hard sell, in our opinion. 2. Is the business really worth £1.8bn? We note that Charles Rolls, one of the company’s founders and deputy chairman, last month sold £73.1m worth of shares. He cashed in £17.3m worth of shares when the company floated three years ago, plus earned £648,000 from Fevertree in pay and bonuses in 2016 alone – so hardly short of cash. Selling a large chunk now sends a negative signal to the market about the company’s future prospects. 3. Main Market plans We’ve heard talk that Fevertree is going to move to London’s Main Market. The company’s advisers say there are no plans at present, but we see this as a short-term risk to the share price if it does happen. The stock is a popular choice for investors wanting AIM shares that qualify for inheritance tax benefits. IHT portfolio managers would be forced to sell if Fevertree went to the Main Market as the shares would no longer qualify for the tax benefits."
10/6/2017
11:13
henchard: Here are some actual numbers for 2016 and forecast numbers for 2017 and 2018 (based on the current share price of 1,714p): ..........2016.....2017.....2018 EPS.......23.86p...27.68p...31.06p Growth....106.2%...16.0%....12.2% P/E.......71.8x....61.9x....55.2x Surely the shares are way too high at these P/Es for the forecast growth. The PEG ratio for 2017 is 3.9. For the PEG to get to the "fair value" benchmark of 1 (let alone a "growth-at-a-reasonable-price" level of below 1) FEVR would have to do EPS of 35.4p in 2017, which is 28% higher than the current consensus and 22% higher than the most bullish analyst, who's forecasting 29p EPS according to the FT. I could see FEVR beating EPS forecasts but not to the extent of 35.4p or higher. The alternative, of course, is that the share price would have to fall significantly for the valuation to become attractive.
Fevertree share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20180219 14:18:15